pharmaphorum4d
Avillion, AstraZeneca asthma rescue treatment given FDA approval
Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...
pharmaphorum2y
AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial
It is currently being developed by AstraZeneca and Avillion in the US under the terms of an agreement signed in 2018. Researchers evaluated the time it took for patients to experience severe ...